NDC 52584-353

LINCOMYCIN

Lincomycin Hydrochloride

LINCOMYCIN is a Intramuscular; Intravenous; Subconjunctival Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by General Injectables And Vaccines, Inc.. The primary component is Lincomycin Hydrochloride.

Product ID52584-353_134321cf-76dd-432d-a459-74c60a65ff97
NDC52584-353
Product TypeHuman Prescription Drug
Proprietary NameLINCOMYCIN
Generic NameLincomycin Hydrochloride
Dosage FormInjection, Solution
Route of AdministrationINTRAMUSCULAR; INTRAVENOUS; SUBCONJUNCTIVAL
Marketing Start Date2020-11-06
Marketing CategoryANDA / ANDA
Application NumberANDA201746
Labeler NameGeneral Injectables and Vaccines, INC.
Substance NameLINCOMYCIN HYDROCHLORIDE
Active Ingredient Strength300 mg/mL
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 52584-353-05

1 VIAL in 1 BAG (52584-353-05) > 10 mL in 1 VIAL
Marketing Start Date2020-11-06
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "LINCOMYCIN" or generic name "Lincomycin Hydrochloride"

NDCBrand NameGeneric Name
0404-9901LINCOMYCINlincomycin hydrochloride
39822-0350Lincomycinlincomycin hydrochloride
39822-0353Lincomycinlincomycin hydrochloride
42571-374LincomycinLincomycin
50090-4533Lincomycinlincomycin hydrochloride
52584-353LINCOMYCINlincomycin hydrochloride
70625-113Lincomycinlincomycin
0009-0555Lincocinlincomycin hydrochloride

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.